This research investigates the impact of live zoster vaccination on cognitive decline in older adults.
Analyzed data on vaccination and cognitive performance in older adults
Assessed cognitive decline following vaccination
Compared outcomes with non-vaccinated individuals
Live zoster vaccination is linked to delayed onset of cognitive decline
Vaccinated individuals show better cognitive performance over time
Benefits extend beyond prevention of herpes zoster infection
Abstract
Live zoster vaccination was associated with delayed onset of cognitive decline, suggesting benefits beyond herpes zoster prevention in aging populations.